Medication info
Diroproprizine 5/160 mg (Amlodipine Besylate, Valsartan)

Diroproprizine 5/160 mg (Amlodipine Besylate, Valsartan)

Prescription medicationTabletOral
Ingredient · strength
Valsartan›160mg / 1 tabletAmlodipine Besylate›6.94mg / 1 tablet
Manufacturer / importer
IYON Pharmaceutical Co., Ltd.
Appearance
Dark yellow oblong film-coated tablet
Packaging
28 tablets (14 tablets/Alu-Alu packaging × 2)
Approval status
Active

MFDS item code 201400082 · Approved 2014.01.09 · Insurance code 658602900

Summary

Main use
Treatment of essential hypertension not controlled with monotherapy
Who takes it
Adults · Children
Adult dose
The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. It is recommended to take it at the same time each day, if possible (e.g., in the morning). It is recommended that the dose of the individual components (amlodipine or valsartan) be adjusted before treatment with this medicine. However, switching directly to this medicine may be considered when blood pressure is not controlled with monotherapy with the individual components, as follows. ㆍ5/80 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 80 mg monotherapy. ㆍ5/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 160 mg monotherapy. ㆍ10/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg or valsartan 160 mg monotherapy, or with 5/160 mg. Patients taking valsartan and amlodipine in combination may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment (creatinine clearance 10mL/min or higher). However, this medicine should not be administered to patients with severe renal impairment (creatinine clearance less than 10mL/min) or to patients on dialysis. Monitoring of potassium levels and creatinine is recommended in patients with moderate renal impairment. Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of valsartan should not exceed 80mg. This medicine should not be administered to patients with severe hepatic impairment, biliary cirrhosis, biliary obstruction, or cholestasis. Patients aged 65 years or older: Use caution when increasing the dose.
Child dose
Use of this medicine is not recommended in pediatric patients under 18 years of age because its safety and efficacy have not been established.

Ingredients

Manufacturer
IYON Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of essential hypertension not controlled with monotherapy

  • Essential hypertension
View approved original text

This medicine assists in the effective management of blood pressure in cases where blood pressure is not sufficiently controlled by the current monotherapy of amlodipine or valsartan. Essential hypertension occurs without a specific cause, and stabilizing blood pressure through treatment is critical. This drug contributes to reducing the risk of cardiovascular diseases by improving blood pressure control when added to existing treatment. Therefore, it is used to improve blood pressure management in patients with hypertension whose blood pressure is not adequately controlled.

How to take

Adult dose

The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. It is recommended to take it at the same time each day, if possible (e.g., in the morning). It is recommended that the dose of the individual components (amlodipine or valsartan) be adjusted before treatment with this medicine. However, switching directly to this medicine may be considered when blood pressure is not controlled with monotherapy with the individual components, as follows. ㆍ5/80 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 80 mg monotherapy. ㆍ5/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 160 mg monotherapy. ㆍ10/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg or valsartan 160 mg monotherapy, or with 5/160 mg. Patients taking valsartan and amlodipine in combination may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment (creatinine clearance 10mL/min or higher). However, this medicine should not be administered to patients with severe renal impairment (creatinine clearance less than 10mL/min) or to patients on dialysis. Monitoring of potassium levels and creatinine is recommended in patients with moderate renal impairment. Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of valsartan should not exceed 80mg. This medicine should not be administered to patients with severe hepatic impairment, biliary cirrhosis, biliary obstruction, or cholestasis. Patients aged 65 years or older: Use caution when increasing the dose.

Child dose

Use of this medicine is not recommended in pediatric patients under 18 years of age because its safety and efficacy have not been established.

Precautions

This drug can cause serious harm to the fetus and newborn if taken during the second and third trimesters of pregnancy, so it should be discontinued immediately upon confirmation of pregnancy. Patients with allergies to the active ingredients, women who are pregnant or breastfeeding, patients with severe kidney or liver dysfunction, and those with specific heart conditions should not take this medication. Patients with low sodium or fluid levels in the body may experience hypotension, so it is essential to check the condition before taking it, and if symptoms of hypotension occur during use, appropriate measures should be taken immediately. Patients with high potassium levels should be cautious when taking this medication along with potassium supplements or other medications that elevate potassium levels, and frequent monitoring of blood potassium levels is required. Patients with kidney problems, kidney transplant recipients, and those with a history of angioedema should also be careful when taking this medicine, and if symptoms of angioedema arise, they should stop taking it immediately. Patients after heart failure or myocardial infarction should carefully monitor their kidney function and blood pressure when taking this medication, as there is a risk of pulmonary edema, and should follow medical instructions. This medicine may cause dizziness or fatigue when driving or operating machinery, so caution is necessary. When taken with other medications, interactions may occur, especially when combined with potassium-sparing diuretics, NSAIDs, certain antibiotics, simvastatin, CYP3A4 inhibitors or inducers. It is advisable to consult a doctor or pharmacist before combining. Women who are pregnant or planning to become pregnant should avoid taking this medication, and breastfeeding women are also advised to refrain from use. It is not recommended for children, as safety and efficacy have not been sufficiently established.

Side effects

Pharyngitis, influenza, hypersensitivity, visual impairment, anxiety, headache, dizziness, drowsiness, positional dizziness, paresthesia, vertigo, tinnitus, tachycardia, palpitations, syncope, orthostatic hypotension, hypotension, cough, throat and laryngeal pain, diarrhea, nausea, abdominal pain, constipation, dry mouth, rash, erythema, hyperhidrosis, rash, pruritus, joint swelling, low back pain, arthritis, muscle cramps, lethargy, polyuria, nocturia, erectile dysfunction, edema, compartment syndrome, facial edema, peripheral edema, fatigue, flushing, weakness, facial flushing, decreased hemoglobin, decreased hematocrit, neutropenia, thrombocytopenia, hypersensitivity including serum sickness, increased serum potassium, vasculitis, elevated liver function tests, vascular edema, myalgia, renal failure, kidney damage, increased serum creatinine, insomnia, decreased libido, pharyngitis, rhinitis, sinusitis, upper respiratory infection, viral infection, diplopia, thrombocytopenia, leukopenia, allergic reaction, hyperglycemia, insomnia, mood changes, tremors, sensory impairment, taste disturbance, peripheral neuropathy, generalized muscle hypertonicity, arrhythmia, bradycardia, atrial fibrillation, ventricular tachycardia, myocardial infarction, vasculitis, dyspnea, rhinitis, vomiting, indigestion, pancreatitis, gastritis, gingival hyperplasia, hepatitis, jaundice, alopecia, purpura, skin depigmentation, photosensitivity reaction, vascular edema, urticaria, erythema multiforme, Stevens-Johnson syndrome, myalgia, urination disorder, nocturnal enuresis, gynecomastia, pain, malaise, chest pain, weight loss, weight gain, elevated liver enzymes, chest discomfort, abdominal discomfort, gastroesophageal reflux disease, neck pain, hypercholesterolemia, hypoglycemia, neurological hyperreactivity, sensory impairment, Stevens-Johnson syndrome, dizziness, fatigue, hypotension, reflex tachycardia, non-cardiogenic pulmonary edema

Not everyone experiences these, and they can vary from person to person.

Storage

This drug should be stored in a tightly closed container to prevent air or moisture from entering and at room temperature between 1 to 30 degrees Celsius. Proper storage can help maintain the effectiveness of the medication.

Appearance and packaging

Appearance

Dark yellow oblong film-coated tablet

Package unit

28 tablets (14 tablets/Alu-Alu packaging × 2)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.